RBC Capital analyst Brian Abrahams maintained a Hold rating on Galapagos (NASDAQ:GLPG) NV on Monday, setting a price target of $150, which is approximately 25.12% below the present share price of $200.31.
Abrahams expects Galapagos NV to post earnings per share (EPS) of -$0.78 for the third quarter of 2020.
The current consensus among 5 TipRanks analysts is for a Moderate Buy rating of shares in Galapagos, with an average price target of $240.17.
The analysts price targets range from a high of $290 to a low of $150.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $98.17 million and a net profit of -$44.59 million. The company's market cap is $13.07 billion.
According to TipRanks.com, RBC Capital analyst Brian Abrahams is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 13.0% and a 55.49% success rate.
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.